FRIDAY, June 21, 2024 -- First-line ibrutinib is associated with better outcomes than chemoimmunotherapy among patients with chronic lymphocytic...

MONDAY, June 24, 2024 -- Moderate- and vigorous-intensity aerobic exercise training are associated with improvements in clinical asthma outcomes,...

MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic...

THURSDAY, June 20, 2024 -- Large language model-based solutions can enhance clinical trial screening performance and reduce costs by automating the...

FRIDAY, June 28, 2024 -- For patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally...

MONDAY, June 24, 2024 -- For patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a...

FRIDAY, June 21, 2024 -- For patients with hypertension, angiotensin receptor blockers (ARBs) are associated with a reduced incidence of epilepsy...

FRIDAY, June 21, 2024 -- The triglyceride-glucose (TyG) index is independently associated with all-cause mortality among patients with heart failure...

WEDNESDAY, June 26, 2024 -- Benralizumab yields a greater histologic response than placebo for patients with eosinophilic esophagitis, but does not...

FRIDAY, June 21, 2024 -- The cumulative risk for advanced gastric cancer varies from 6.5 to 10.3 percent for carriers of germline CDH1...